Entrepreneur UK's London 100: Unai
Unai is a UK-crafted sparkling drink that harnesses the wellness-boosting benefits of functional mushrooms, offering a refreshing approach to mindful living.
The brand is centered around themes of grounding and being present, promoting a lifestyle rooted in balance and intention.
Owned by London-based Matthew Glover, Unai is part of a growing movement that blends natural ingredients with modern wellness, providing consumers with a functional beverage that supports both body and mind.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
British expats 'shocked' at price of essential item in Australia: 'Mental'
It's one of the main cost of living wallet-pinchers that most Aussies dread. For many households, filling up the car each week can be a budget strain, but several British expats had a shock at the bowser recently for an entirely different reason – they couldn't believe how cheap Aussie fuel is compared to the UK. British expat Steff Littleford, currently living in Perth, took to TikTok to share her disbelief after seeing local fuel prices and converting the currency. 'Things that absolutely shock me in Australia. Petrol — 76p. Tell me why in the UK it's like £1.40, £1.50,' she said. '76 f***ing pence a litre in Australia. Mental.' Another UK expat Josie agreed, saying it was one of the 'biggest shocks' about moving to Australia. 'Fuel here is cheap compared to the UK. The average fuel price in Australia is around $1.60 [a litre]. 'In the UK, when you convert it to Australian dollars, it comes out at $2.90. That's basically what you pay here in super remote regional areas.' Aussie floored by petrol prices in the UK Across the other side of the world, founder of Paul Maric, found himself stunned by the prices at a petrol station in the UK. He was touring the country in a twin-turbo V8 BMW M5 Touring car, which can be expensive to run, and took a photograph of the bowser showing £181.9 per litre — around A$3.76. 'I was shocked at how much Britons pay for fuel compared to Australia. People in Australia jump up and down about the cost of fuel, but in reality, we pay barely anything compared to the UK,' he told Yahoo News. 'Even if you have a look at California, we are getting a much better deal when it comes to fuel costs.' Thankfully, his car was a plug-in hybrid, so he was able to use electric power as well to ease the cost of fuel. But even when it came to charging, Paul noticed it was about twice the price of a public EV charger in Australia. 'Charging an EV in the UK is outrageously expensive compared to Australia. We paid £0.49/kWh for a slower charger and £0.79/kWh for a fast charger. We pay about half that in Australia to charge an EV on public charging infrastructure,' he said. So why the huge price difference? According to NRMA spokesperson Peter Khoury, the answer depends on where in the fuel cycle you're looking — and how much tax each country is paying. 'They're probably looking at prices at the bottom of the cycle and going, 'Oh my God', then doing the conversion to pounds, but what they're not taking into consideration is that they pay more tax than we do,' he told Yahoo. 'Australians pay less tax on fuel than Europeans and Kiwis — but more than Americans. That's a big factor.' At the time of writing, the wholesale fuel price sits at 159.6 cents per litre, with Sydney currently near the bottom of the petrol price cycle. Khoury said comparing prices in London with the bottom of the cycle here in Australia will, of course, seem cheap. 'We have price cycles, and when we're at the top of the cycle, that gap's going to be a lot smaller. But if it's comparing it to the bottom of the cycle, it's a lot bigger.' Still, despite how it looks from across the pond, Khoury said many Australians are genuinely struggling to keep up with the weekly cost of fuel. 'We know that there are [people struggling] — especially when they're filling up at the top of the cycle,' he said. Do you have a story tip? Email: newsroomau@ You can also follow us on Facebook, Instagram, TikTok, Twitter and YouTube.
Yahoo
24 minutes ago
- Yahoo
Some firms ‘earn much more money than it costs to provide pay monthly insurance'
Some firms earn much more money for providing insurance premiums paid by customers in monthly instalments than the cost of providing the cover, the regulator has said. Some 'pay monthly' customers may also face a higher charge for the underlying insurance premium – a practice sometimes described as 'double dipping'. Concerns have been raised that the decision to pay monthly may be factored into the pricing of the underlying insurance premium itself. The Financial Conduct Authority's (FCA) rules require firms should not increase the insurance premium to customers using premium finance without objective and reasonable basis for the change. Some insurers have said the choice of payment method is correlated with insurance risk for those paying monthly. The FCA's update paper on its premium finance market study said: 'If we see evidence of firms not having an objective and reasonable basis for taking such an approach, we will consider our supervisory approach on a firm-by-firm basis.' The update added: 'Where firms charge for premium finance, revenues appear to materially exceed costs for some providers. 'Whereas the profit margin earned on a core insurance policy may be relatively low, we see margins on premium finance that are somewhat higher. 'Different business models will have different ways of recovering costs. 'In some cases, they recover all costs through the insurance product itself, or recoup returns on lower margin insurance product through higher APRs (annual percentage rates).' The FCA's analysis found premium finance margins (revenue less economic costs as a proportion of revenue) ranging between 14% and 62% across insurers, intermediary lenders, intermediary brokers and specialist premium finance providers (SPFPs) in the period between 2018 and 2023. SPFPs averaged the lowest margins out of these four, with a weighted average margin of 24% between 2018 and 2023. Insurers had the highest weighted average margins of 53%, the regulator said. Firms offering premium finance incur some operational costs, for instance staff, IT and compliance. Lenders also incur funding costs or must sacrifice investment income by delaying the date of full payment, it added. Consumer credit products are also priced to compensate firms for high levels of bad debt or default, among other costs. The update said: 'Nevertheless, we find that some bad debt is incurred by premium finance lenders (with the ratio of bad debt to loan balanceranging from 0.6% for SPFPs to 1% for intermediary lenders) but not at the levels of other consumer credit products (1.9% for credit cards based on a sample of retail banks).' The FCA said premium finance is an important way of paying for insurance, and in 2023 it was used for around 48% of motor and home policies. For some consumers, premium finance is a choice, but for many, especially those in more vulnerable groups, it is a necessity because they cannot afford to pay annually, the regulator said. In 2024, 60% of motor and 41% of home (buildings and contents combined) policyholders who paid by instalments did so because they could not afford to pay in a single annual payment, it added. There is wide variation in the rates firms charge for paying by instalments. Typically, when firms charge extra for premium finance, the APRs are in the range of 20% to 30% but almost 20% of consumers pay more than 30%, the report said. Around 60% of consumers pay headline APRs that are between 20% and 30%. This would cost an extra £19 to £28 on an illustrative home policy and £35 to £51 on an illustrative motor policy – suggesting that it costs consumers typically between 8% and 11% more to pay monthly rather than annually, the regulator said. Interest rates on consumer credit vary across products and between consumers, but these APRs compare with monthly advertised interest rates in 2023 of 35% for overdrafts, 11% on a £5,000 personal loan and 23% for credit cards issued by financial institutions as reported by the Bank of England, the FCA's paper said. It added: 'Our own data, which captures a larger proportion of the market including cards marketed as 'credit builders', shows average APRs on new credit card agreements ranged between 26-32% at the end of 2023.' The cost of paying monthly also differs substantially between motor and home insurance, the FCA said. More than a third of home insurance customers pay no more for paying monthly than annually, compared with less than 3% of motor insurance customers. Some firms have indicated that cancellations and changes of policy tend to occur at a higher rate in motor than home, which leads to higher costs for providing motor insurance premium finance, the regulator said. Zero per cent finance options for home insurance also seem to be more common than in motor insurance in part because there is greater prevalence of buying direct from the insurer, enabling firms to more easily offset the funding and operational cost of offering monthly payments. The FCA now plans to carry out further analysis to look more closely at higher-priced products, the value these products provide, profitability, and the extent to which these prices are paid by vulnerable customers. Where it finds products with prices which are not reflective of the value offered, the regulator said it will be challenging firms to make sure they have considered all these aspects fully. The FCA will also investigate the extent to which consumers can effectively compare premium finance with other credit products. Its premium finance market study was launched in October 2024 as part of wider work on motor and home insurance, following concerns that premium finance may not represent fair value for some customers and that competition may not be functioning effectively. The FCA's findings are based on evidence and data that it has gathered from a request for information (RFI) from a sample of firms. It is seeking comments to further inform the next phase of the market study, and is inviting views to be sent by 5pm on September 30 2025.
Medscape
25 minutes ago
- Medscape
More Than a Number: Sleep Quality Next Target for CV Health
From the Dalai Lama's claim that it is the 'best meditation' to Benjamin Franklin's insistence that it makes a person 'healthy, wealthy, and wise,' a good night's sleep has long been touted as the secret to a healthy life. And the American Heart Association (AHA) agrees. In 2022, the AHA added sleep duration to Life's Simple 8, their checklist for optimal heart health. This was on the basis of strong evidence from epidemiologic studies linking sleep duration to poor cardiometabolic outcomes, such as obesity, type 2 diabetes, and stroke. But emerging research suggests that it's time for cardiologists to consider more than just sleep duration. 'Lack of sleep has been long known to be associated with coronary heart disease,' said Martha Gulati, MD, the director of Preventive Cardiology in the Smidt Heart Institute at Cedars-Sinai, in Los Angeles. Gulati emphasized that achieving adequate sleep (between 7 and 9 hours) has also been associated with healthy traits, such as better blood pressure, better cholesterol control, and healthy weight. Martha Gulati, MD However, the number of hours a person sleeps each night just scratches the surface she said. Research has shown that consistency and preferred timing of sleep, known as sleep chronotype, are important as well. In a 2023 UK-based study, middle-aged adults who considered themselves night owls — the evening sleep chronotype — had signs of potentially detrimental cardiac remodeling on cardiac magnetic resonance imaging compared with morning folks. And the damage may start early. In a recent study in adolescents, shorter sleep duration was associated with adverse markers of left ventricular wall remodeling and liver fat accumulation suggesting a cumulative effect on health, according to the authors. The MESA Sleep Ancillary study found that people with greater irregularity in sleep patterns — such as falling asleep at different times each night — had a higher coronary artery calcium burden than those with more regular sleep patterns. Because sleep is associated with a range of cardiometabolic diseases, Julie Marcus, MD, a cardiologist at Weill Cornell Medicine/New York Presbyterian Hospital, New York City, said addressing poor sleep has become an important but underappreciated aspect of maintaining a healthy heart. Julie Marcus, MD She added that patients also need to be aware that poor sleep can affect their health and what the various components of healthy sleep are. 'Beyond saying do you snore [or] stop breathing at night and do you sleep between 7 and 9 hours, there's so much more to sleep that is important,' Marcus said. Expanding the Definition of Sleep Health Early this year, the AHA published an updated scientific statement that addresses multidimensional sleep health. This includes duration, timing, regularity, sleep-related daytime functioning, satisfaction, continuity — the ability to initiate and maintain sleep — and sleep architecture, or the amount and timing of the various sleep stages. Marie-Pierre St-Onge, PhD, a sleep health researcher and lead author of the AHA statement, explained that it was developed to promote the breadth of new research. 'We want to let people know that sleep is more than just how long you sleep at night,' said St-Onge, who is the director of the Center of Excellence for Sleep and Circadian Research at Columbia University, New York City. Marie-Pierre St-Onge, PhD For example, she explained excessive daytime sleepiness has been associated with cardiovascular disease, coronary heart disease, stroke, and all-cause mortality. Similarly, sleep disturbances have been linked to hypertension, arterial stiffness, and coronary heart disease. Understanding Poor Sleep's Mechanism of Action St-Onge emphasized that new research has also increased understanding around the associations between poor sleep and worsening cardiometabolic outcomes. Her research has shown that sleep restriction increases oxidative stress in the lining of the arteries that could lead to endothelial dysfunction. Short sleep also impairs the body's ability to counteract this oxidative stress. 'We see immune suppression from poor sleep duration and poor sleep quality,' St-Onge said. In addition, we have found links between sleep regularity and eating patterns, St-Onge noted. Gulati believes that the AHA statement represents an opportunity to raise awareness among patients, cardiologists, and clinical researchers about the importance of better understanding these causal effects of poor multidimensional sleep health. 'I think it is also a call to action to improve the assessment of sleep, particularly in research so we can rigorously assess these components,' Gulati said. 'We need to know what interventions can improve components of sleep as well, and their effect on cardiovascular health. Those knowledge gaps need to be closed.' Talking About Sleep Health Those knowledge gaps are why the statement did not offer guidance for clinical approaches, but St-Onge emphasized the importance of educating and discussing this topic with patients now. She recommended asking an open-ended question: 'How's your sleep?' 'That opens up a conversation for people to express exactly what's bothering them with their sleep.' For example, she said, 'It may be they get plenty of hours of sleep, but they lie there awake for way too long, or they're having a hard time falling asleep, or they get a lot of sleep, but they still wake up not feeling refreshed during the day.' Starting the conversation — and documenting it in clinical notes — will be the first step to helping patients with poor sleep health, she said. Marcus agreed that cardiologists should make time to discuss sleep health with patients, even though it can be more complicated than addressing cholesterol or blood pressure because 'sleep is not a number.' Still, she said that understanding a patient's poor sleep health can also provide physicians with new modifiable risk factors for improving their cardiovascular health. 'Sleep is the next target,' Marcus said. 'We know it impacts health, and it's just a matter of how do we screen for it.' Gulati reported financial relationships with Boehringer Ingelheim Pharmaceuticals, Medtronic, Merck & Co., New Amsterdam, and Zoll.
